<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Exon 20 &#8211; Grupo TTD</title>
	<atom:link href="https://grupottd.org/tag/exon-20/feed/" rel="self" type="application/rss+xml" />
	<link>https://grupottd.org</link>
	<description>Grupo de Tratamiento de los Tumores Digestivos</description>
	<lastBuildDate>Tue, 23 Jun 2026 08:56:04 +0000</lastBuildDate>
	<language>es</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.4</generator>

<image>
	<url>https://grupottd.org/wp-content/uploads/2026/03/cropped-Logo-TTD-favicon-32x32.png</url>
	<title>Exon 20 &#8211; Grupo TTD</title>
	<link>https://grupottd.org</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Aspirina en bajas dosis para cáncer colorrectal localizado con alteración en PI3K</title>
		<link>https://grupottd.org/aspirina-en-bajas-dosis-para-cancer-colorrectal-localizado-con-alteracion-en-pi3k/</link>
					<comments>https://grupottd.org/aspirina-en-bajas-dosis-para-cancer-colorrectal-localizado-con-alteracion-en-pi3k/#respond</comments>
		
		<dc:creator><![CDATA[Susana Rodríguez]]></dc:creator>
		<pubDate>Tue, 23 Jun 2026 08:55:32 +0000</pubDate>
				<category><![CDATA[Artículos comentados]]></category>
		<category><![CDATA[ALASCCA]]></category>
		<category><![CDATA[Aspirina]]></category>
		<category><![CDATA[Cancer Colorrectal]]></category>
		<category><![CDATA[Colangiocarcinoma intrahepático;Neoadyuvancia;NEOGOLP; anti-PD1 ;Supervivencia libre de enfermedad;Alto riesgo; CA 19.9; enfermedad resecable;Resección R0;Respuesta completa patológica ; toxicidad.]]></category>
		<category><![CDATA[Estadio II]]></category>
		<category><![CDATA[Estadio III]]></category>
		<category><![CDATA[Exon 20]]></category>
		<category><![CDATA[Exon 9]]></category>
		<category><![CDATA[Pi3k]]></category>
		<category><![CDATA[Supervivencia Libre Enfermedad]]></category>
		<guid isPermaLink="false">https://grupottd.org/?p=13339</guid>

					<description><![CDATA[El ensayo ALASCCA demuestra que aspirina 160 mg, día reduce de forma significativa la recurrencia en CCR localizado con alteraciones PI3K: 7,7% vs. 14,1% en mutaciones hotspot (HR 0,49) y beneficio similar en otras variantes (HR 0,42). Mejora la SLE a 3 años. Toxicidad aceptable, con más eventos graves (16,8% vs. 11,6%).

CONCLUSIONES: 
•  Aspirina reduce de forma significativa la recurrencia en CCR localizado con alteraciones PI3K.
•  Efecto consistente en mutaciones hotspot y en otras variantes del eje PI3K.
•  Perfil de seguridad aceptable, con ligero aumento de eventos graves.
•  El estudio respalda selección molecular PI3K para guiar terapia adyuvante.
]]></description>
			<style id="elementor-post-13339">.elementor-13339 .elementor-element.elementor-element-3ce7a18b{--display:flex;--padding-top:0px;--padding-bottom:0px;--padding-left:0px;--padding-right:0px;}.elementor-13339 .elementor-element.elementor-element-658f317a > .elementor-widget-container{padding:0px 0px 20px 0px;}.elementor-13339 .elementor-element.elementor-element-4a299971{--display:flex;--flex-direction:column;--container-widget-width:100%;--container-widget-height:initial;--container-widget-flex-grow:0;--container-widget-align-self:initial;--flex-wrap-mobile:wrap;--gap:20px 40px;--row-gap:20px;--column-gap:40px;border-style:none;--border-style:none;--margin-top:0px;--margin-bottom:20px;--margin-left:0px;--margin-right:0px;--padding-top:20px;--padding-bottom:20px;--padding-left:30px;--padding-right:30px;}.elementor-13339 .elementor-element.elementor-element-4a299971:not(.elementor-motion-effects-element-type-background), .elementor-13339 .elementor-element.elementor-element-4a299971 > .elementor-motion-effects-container > .elementor-motion-effects-layer{background-color:#7A7A7A0D;}.elementor-13339 .elementor-element.elementor-element-2264f626{--display:flex;--justify-content:flex-start;--gap:5px 0px;--row-gap:5px;--column-gap:0px;--padding-top:0px;--padding-bottom:0px;--padding-left:0px;--padding-right:0px;}.elementor-13339 .elementor-element.elementor-element-571428a8{--display:flex;--flex-direction:row;--container-widget-width:calc( ( 1 - var( --container-widget-flex-grow ) ) * 100% );--container-widget-height:100%;--container-widget-flex-grow:1;--container-widget-align-self:stretch;--flex-wrap-mobile:wrap;--align-items:center;--gap:4px 8px;--row-gap:4px;--column-gap:8px;--padding-top:0px;--padding-bottom:0px;--padding-left:0px;--padding-right:0px;}.elementor-13339 .elementor-element.elementor-element-c9b8ac6 .elementor-heading-title{font-size:var( --e-global-typography-d3d4f5c-font-size );line-height:var( --e-global-typography-d3d4f5c-line-height );color:var( --e-global-color-accent );}.elementor-13339 .elementor-element.elementor-element-522b0f51 .elementor-heading-title{font-size:var( --e-global-typography-a7220b8-font-size );font-weight:var( --e-global-typography-a7220b8-font-weight );line-height:var( --e-global-typography-a7220b8-line-height );color:#646464;}.elementor-13339 .elementor-element.elementor-element-241536ae{--display:flex;--flex-direction:row;--container-widget-width:calc( ( 1 - var( --container-widget-flex-grow ) ) * 100% );--container-widget-height:100%;--container-widget-flex-grow:1;--container-widget-align-self:stretch;--flex-wrap-mobile:wrap;--align-items:center;--gap:4px 8px;--row-gap:4px;--column-gap:8px;--padding-top:0px;--padding-bottom:0px;--padding-left:0px;--padding-right:0px;}.elementor-13339 .elementor-element.elementor-element-148cd8bf .elementor-heading-title{font-size:var( --e-global-typography-d3d4f5c-font-size );line-height:var( --e-global-typography-d3d4f5c-line-height );color:var( --e-global-color-accent );}.elementor-13339 .elementor-element.elementor-element-2294010a .elementor-heading-title{font-size:var( --e-global-typography-a7220b8-font-size );font-weight:var( --e-global-typography-a7220b8-font-weight );line-height:var( --e-global-typography-a7220b8-line-height );color:#646464;}.elementor-13339 .elementor-element.elementor-element-392a579f{--display:flex;--flex-direction:row;--container-widget-width:calc( ( 1 - var( --container-widget-flex-grow ) ) * 100% );--container-widget-height:100%;--container-widget-flex-grow:1;--container-widget-align-self:stretch;--flex-wrap-mobile:wrap;--align-items:center;--gap:4px 8px;--row-gap:4px;--column-gap:8px;--flex-wrap:wrap;--padding-top:0px;--padding-bottom:0px;--padding-left:0px;--padding-right:0px;}.elementor-13339 .elementor-element.elementor-element-31655606 .elementor-heading-title{font-size:var( --e-global-typography-d3d4f5c-font-size );line-height:var( --e-global-typography-d3d4f5c-line-height );color:var( --e-global-color-accent );}.elementor-13339 .elementor-element.elementor-element-34dd77b0 .elementor-heading-title{font-size:14px;font-weight:400;line-height:1.4em;color:#646464;}.elementor-13339 .elementor-element.elementor-element-4e9ff277{--display:flex;--flex-direction:row;--container-widget-width:calc( ( 1 - var( --container-widget-flex-grow ) ) * 100% );--container-widget-height:100%;--container-widget-flex-grow:1;--container-widget-align-self:stretch;--flex-wrap-mobile:wrap;--align-items:center;--gap:4px 8px;--row-gap:4px;--column-gap:8px;--flex-wrap:wrap;--padding-top:0px;--padding-bottom:0px;--padding-left:0px;--padding-right:0px;}.elementor-13339 .elementor-element.elementor-element-8521b33 .elementor-heading-title{font-size:var( --e-global-typography-d3d4f5c-font-size );line-height:var( --e-global-typography-d3d4f5c-line-height );color:var( --e-global-color-accent );}.elementor-13339 .elementor-element.elementor-element-5bb74bd8 .elementor-heading-title{font-size:14px;font-weight:400;line-height:1.4em;color:#646464;}.elementor-13339 .elementor-element.elementor-element-67254483{--display:flex;--padding-top:0px;--padding-bottom:0px;--padding-left:0px;--padding-right:0px;}.elementor-13339 .elementor-element.elementor-element-33cb564e{--display:flex;--margin-top:20px;--margin-bottom:0px;--margin-left:0px;--margin-right:0px;--padding-top:0px;--padding-bottom:0px;--padding-left:0px;--padding-right:0px;}.elementor-13339 .elementor-element.elementor-element-4679cddc .elementor-button{background-color:var( --e-global-color-9f14806 );font-weight:500;fill:var( --e-global-color-primary );color:var( --e-global-color-primary );border-style:solid;border-width:1px 1px 1px 1px;}.elementor-13339 .elementor-element.elementor-element-4679cddc .elementor-button:hover, .elementor-13339 .elementor-element.elementor-element-4679cddc .elementor-button:focus{background-color:var( --e-global-color-primary );color:var( --e-global-color-9f14806 );}.elementor-13339 .elementor-element.elementor-element-4679cddc .elementor-button:hover svg, .elementor-13339 .elementor-element.elementor-element-4679cddc .elementor-button:focus svg{fill:var( --e-global-color-9f14806 );}.elementor-13339 .elementor-element.elementor-element-41955f1d .elementor-button{background-color:var( --e-global-color-9f14806 );font-weight:500;fill:var( --e-global-color-primary );color:var( --e-global-color-primary );border-style:solid;border-width:1px 1px 1px 1px;}.elementor-13339 .elementor-element.elementor-element-41955f1d .elementor-button:hover, .elementor-13339 .elementor-element.elementor-element-41955f1d .elementor-button:focus{background-color:var( --e-global-color-primary );color:var( --e-global-color-9f14806 );}.elementor-13339 .elementor-element.elementor-element-41955f1d .elementor-button:hover svg, .elementor-13339 .elementor-element.elementor-element-41955f1d .elementor-button:focus svg{fill:var( --e-global-color-9f14806 );}.elementor-13339 .elementor-element.elementor-element-67f1d66d{--display:flex;--flex-direction:row;--container-widget-width:calc( ( 1 - var( --container-widget-flex-grow ) ) * 100% );--container-widget-height:100%;--container-widget-flex-grow:1;--container-widget-align-self:stretch;--flex-wrap-mobile:wrap;--align-items:center;--gap:10px 10px;--row-gap:10px;--column-gap:10px;--padding-top:30px;--padding-bottom:0px;--padding-left:0px;--padding-right:0px;}.elementor-13339 .elementor-element.elementor-element-9c6d187 > .elementor-widget-container{padding:5px 5px 5px 5px;border-style:solid;border-width:1px 1px 1px 1px;border-color:#4747475E;border-radius:46px 46px 46px 46px;}.elementor-13339 .elementor-element.elementor-element-59554da0 .elementor-icon-box-wrapper{text-align:start;}.elementor-13339 .elementor-element.elementor-element-59554da0 .elementor-icon-box-title{margin-block-end:0px;}.elementor-13339 .elementor-element.elementor-element-59554da0 .elementor-icon-box-title, .elementor-13339 .elementor-element.elementor-element-59554da0 .elementor-icon-box-title a{font-size:13px;}.elementor-13339 .elementor-element.elementor-element-59554da0 .elementor-icon-box-description{font-size:14px;line-height:15px;}@media(max-width:1366px){.elementor-13339 .elementor-element.elementor-element-c9b8ac6 .elementor-heading-title{font-size:var( --e-global-typography-d3d4f5c-font-size );line-height:var( --e-global-typography-d3d4f5c-line-height );}.elementor-13339 .elementor-element.elementor-element-522b0f51 .elementor-heading-title{font-size:var( --e-global-typography-a7220b8-font-size );line-height:var( --e-global-typography-a7220b8-line-height );}.elementor-13339 .elementor-element.elementor-element-148cd8bf .elementor-heading-title{font-size:var( --e-global-typography-d3d4f5c-font-size );line-height:var( --e-global-typography-d3d4f5c-line-height );}.elementor-13339 .elementor-element.elementor-element-2294010a .elementor-heading-title{font-size:var( --e-global-typography-a7220b8-font-size );line-height:var( --e-global-typography-a7220b8-line-height );}.elementor-13339 .elementor-element.elementor-element-31655606 .elementor-heading-title{font-size:var( --e-global-typography-d3d4f5c-font-size );line-height:var( --e-global-typography-d3d4f5c-line-height );}.elementor-13339 .elementor-element.elementor-element-8521b33 .elementor-heading-title{font-size:var( --e-global-typography-d3d4f5c-font-size );line-height:var( --e-global-typography-d3d4f5c-line-height );}}@media(max-width:1200px){.elementor-13339 .elementor-element.elementor-element-571428a8{--flex-direction:row;--container-widget-width:initial;--container-widget-height:100%;--container-widget-flex-grow:1;--container-widget-align-self:stretch;--flex-wrap-mobile:wrap;--gap:0px 8px;--row-gap:0px;--column-gap:8px;--flex-wrap:wrap;}.elementor-13339 .elementor-element.elementor-element-241536ae{--flex-direction:row;--container-widget-width:initial;--container-widget-height:100%;--container-widget-flex-grow:1;--container-widget-align-self:stretch;--flex-wrap-mobile:wrap;--gap:0px 8px;--row-gap:0px;--column-gap:8px;--flex-wrap:wrap;}.elementor-13339 .elementor-element.elementor-element-392a579f{--flex-direction:row;--container-widget-width:initial;--container-widget-height:100%;--container-widget-flex-grow:1;--container-widget-align-self:stretch;--flex-wrap-mobile:wrap;--gap:0px 8px;--row-gap:0px;--column-gap:8px;--flex-wrap:wrap;}.elementor-13339 .elementor-element.elementor-element-4e9ff277{--flex-direction:row;--container-widget-width:initial;--container-widget-height:100%;--container-widget-flex-grow:1;--container-widget-align-self:stretch;--flex-wrap-mobile:wrap;--gap:0px 8px;--row-gap:0px;--column-gap:8px;--flex-wrap:wrap;}}@media(max-width:1024px){.elementor-13339 .elementor-element.elementor-element-c9b8ac6 .elementor-heading-title{font-size:var( --e-global-typography-d3d4f5c-font-size );line-height:var( --e-global-typography-d3d4f5c-line-height );}.elementor-13339 .elementor-element.elementor-element-522b0f51 .elementor-heading-title{font-size:var( --e-global-typography-a7220b8-font-size );line-height:var( --e-global-typography-a7220b8-line-height );}.elementor-13339 .elementor-element.elementor-element-148cd8bf .elementor-heading-title{font-size:var( --e-global-typography-d3d4f5c-font-size );line-height:var( --e-global-typography-d3d4f5c-line-height );}.elementor-13339 .elementor-element.elementor-element-2294010a .elementor-heading-title{font-size:var( --e-global-typography-a7220b8-font-size );line-height:var( --e-global-typography-a7220b8-line-height );}.elementor-13339 .elementor-element.elementor-element-31655606 .elementor-heading-title{font-size:var( --e-global-typography-d3d4f5c-font-size );line-height:var( --e-global-typography-d3d4f5c-line-height );}.elementor-13339 .elementor-element.elementor-element-8521b33 .elementor-heading-title{font-size:var( --e-global-typography-d3d4f5c-font-size );line-height:var( --e-global-typography-d3d4f5c-line-height );}}@media(max-width:767px){.elementor-13339 .elementor-element.elementor-element-c9b8ac6 .elementor-heading-title{font-size:var( --e-global-typography-d3d4f5c-font-size );line-height:var( --e-global-typography-d3d4f5c-line-height );}.elementor-13339 .elementor-element.elementor-element-522b0f51 .elementor-heading-title{font-size:var( --e-global-typography-a7220b8-font-size );line-height:var( --e-global-typography-a7220b8-line-height );}.elementor-13339 .elementor-element.elementor-element-148cd8bf .elementor-heading-title{font-size:var( --e-global-typography-d3d4f5c-font-size );line-height:var( --e-global-typography-d3d4f5c-line-height );}.elementor-13339 .elementor-element.elementor-element-2294010a .elementor-heading-title{font-size:var( --e-global-typography-a7220b8-font-size );line-height:var( --e-global-typography-a7220b8-line-height );}.elementor-13339 .elementor-element.elementor-element-31655606 .elementor-heading-title{font-size:var( --e-global-typography-d3d4f5c-font-size );line-height:var( --e-global-typography-d3d4f5c-line-height );}.elementor-13339 .elementor-element.elementor-element-8521b33 .elementor-heading-title{font-size:var( --e-global-typography-d3d4f5c-font-size );line-height:var( --e-global-typography-d3d4f5c-line-height );}}</style>							<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="13339" class="elementor elementor-13339" data-elementor-post-type="post">
				<div class="elementor-element elementor-element-3ce7a18b e-flex e-con-boxed e-con e-parent" data-id="3ce7a18b" data-element_type="container" data-e-type="container">
					<div class="e-con-inner">
				<div class="elementor-element elementor-element-658f317a elementor-widget elementor-widget-heading" data-id="658f317a" data-element_type="widget" data-e-type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<h2 class="elementor-heading-title elementor-size-default">Aspirina en bajas dosis para cáncer colorrectal localizado con alteración en PI3K</h2>				</div>
				</div>
					</div>
				</div>
		<div class="elementor-element elementor-element-4a299971 e-con-full e-flex e-con e-child" data-id="4a299971" data-element_type="container" data-e-type="container" data-settings="{&quot;background_background&quot;:&quot;classic&quot;}">
		<div class="elementor-element elementor-element-2264f626 e-con-full e-flex e-con e-child" data-id="2264f626" data-element_type="container" data-e-type="container">
		<div class="elementor-element elementor-element-571428a8 e-con-full e-flex e-con e-child" data-id="571428a8" data-element_type="container" data-e-type="container">
				<div class="elementor-element elementor-element-c9b8ac6 elementor-widget elementor-widget-heading" data-id="c9b8ac6" data-element_type="widget" data-e-type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<h5 class="elementor-heading-title elementor-size-default">Edición:</h5>				</div>
				</div>
				<div class="elementor-element elementor-element-522b0f51 elementor-widget elementor-widget-heading" data-id="522b0f51" data-element_type="widget" data-e-type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<p class="elementor-heading-title elementor-size-default">Publicación científica 2026</p>				</div>
				</div>
				</div>
		<div class="elementor-element elementor-element-241536ae e-con-full e-flex e-con e-child" data-id="241536ae" data-element_type="container" data-e-type="container">
				<div class="elementor-element elementor-element-148cd8bf elementor-widget elementor-widget-heading" data-id="148cd8bf" data-element_type="widget" data-e-type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<h4 class="elementor-heading-title elementor-size-default">Fecha:</h4>				</div>
				</div>
				<div class="elementor-element elementor-element-2294010a elementor-widget elementor-widget-heading" data-id="2294010a" data-element_type="widget" data-e-type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<p class="elementor-heading-title elementor-size-default">23 de junio de 2026</p>				</div>
				</div>
				</div>
		<div class="elementor-element elementor-element-392a579f e-con-full e-flex e-con e-child" data-id="392a579f" data-element_type="container" data-e-type="container">
				<div class="elementor-element elementor-element-31655606 elementor-widget elementor-widget-heading" data-id="31655606" data-element_type="widget" data-e-type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<h4 class="elementor-heading-title elementor-size-default">Autores:</h4>				</div>
				</div>
				<div class="elementor-element elementor-element-34dd77b0 elementor-widget elementor-widget-heading" data-id="34dd77b0" data-element_type="widget" data-e-type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<p class="elementor-heading-title elementor-size-default">Martling A, Hed Myrberg I, Nilbert M, Grönberg H, Granath F, Eklund M, Öresland T, Iversen LH, Haapamäki C, Janson M, Westberg K, Segelman J, Ersson U, Prytz M, Angenete E, Bergström R, Mayrhofer M, Glimelius B, Lindberg J; ALASCCA Study Group</p>				</div>
				</div>
				</div>
		<div class="elementor-element elementor-element-4e9ff277 e-con-full e-flex e-con e-child" data-id="4e9ff277" data-element_type="container" data-e-type="container">
				<div class="elementor-element elementor-element-8521b33 elementor-widget elementor-widget-heading" data-id="8521b33" data-element_type="widget" data-e-type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<h4 class="elementor-heading-title elementor-size-default">Autora de la revisión:</h4>				</div>
				</div>
				<div class="elementor-element elementor-element-5bb74bd8 elementor-widget elementor-widget-heading" data-id="5bb74bd8" data-element_type="widget" data-e-type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<p class="elementor-heading-title elementor-size-default">Fernando Garicano. Hospital Universitario Galdakao-Usansolo (Miembro de la Asamblea General del Grupo TTD)</p>				</div>
				</div>
				</div>
				</div>
				</div>
		<div class="elementor-element elementor-element-67254483 e-flex e-con-boxed e-con e-parent" data-id="67254483" data-element_type="container" data-e-type="container">
					<div class="e-con-inner">
				<div class="elementor-element elementor-element-71cc5159 elementor-widget elementor-widget-text-editor" data-id="71cc5159" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p>El ensayo ALASCCA demuestra que <strong>aspirina 160 mg, día</strong> reduce de forma significativa la <strong>recurrencia</strong> en CCR localizado con <strong>alteraciones PI3K</strong>: 7,7% vs. 14,1% en mutaciones hotspot (HR 0,49) y beneficio similar en otras variantes (HR 0,42). Mejora la SLE a 3 años. Toxicidad aceptable, con más eventos graves (16,8% vs. 11,6%).</p><p> </p><p>CONCLUSIONES:</p><ul><li><strong>Aspirina</strong> reduce de forma significativa la recurrencia en CCR localizado con alteraciones PI3K.</li><li>Efecto <strong>consistente</strong> en mutaciones hotspot y en otras variantes del eje PI3K.</li><li>Perfil de seguridad aceptable, con ligero aumento de eventos graves.</li><li>El estudio respalda <strong>selección molecular PI3K</strong> para guiar terapia adyuvante.</li></ul>								</div>
				</div>
					</div>
				</div>
		<div class="elementor-element elementor-element-33cb564e e-flex e-con-boxed e-con e-parent" data-id="33cb564e" data-element_type="container" data-e-type="container">
					<div class="e-con-inner">
				<div class="elementor-element elementor-element-4679cddc elementor-align-center elementor-widget elementor-widget-button" data-id="4679cddc" data-element_type="widget" data-e-type="widget" data-widget_type="button.default">
				<div class="elementor-widget-container">
									<div class="elementor-button-wrapper">
					<a class="elementor-button elementor-button-link elementor-size-sm" href="https://grupottd.org/articulos-comentados/low-dose-aspirin-for-pi3k-altered-localized-colorectal-cancer-2/">
						<span class="elementor-button-content-wrapper">
									<span class="elementor-button-text">Ver artículo comentado TTD completo</span>
					</span>
					</a>
				</div>
								</div>
				</div>
				<div class="elementor-element elementor-element-41955f1d elementor-align-center elementor-widget elementor-widget-button" data-id="41955f1d" data-element_type="widget" data-e-type="widget" data-widget_type="button.default">
				<div class="elementor-widget-container">
									<div class="elementor-button-wrapper">
					<a class="elementor-button elementor-button-link elementor-size-sm" href="https://pubmed.ncbi.nlm.nih.gov/40961426/" target="_blank">
						<span class="elementor-button-content-wrapper">
									<span class="elementor-button-text">Enlace al artículo original</span>
					</span>
					</a>
				</div>
								</div>
				</div>
					</div>
				</div>
		<div class="elementor-element elementor-element-67f1d66d e-con-full e-flex e-con e-child" data-id="67f1d66d" data-element_type="container" data-e-type="container">
				<div class="elementor-element elementor-element-9c6d187 elementor-widget elementor-widget-image" data-id="9c6d187" data-element_type="widget" data-e-type="widget" data-widget_type="image.default">
				<div class="elementor-widget-container">
															<img decoding="async" src="https://grupottd.org/wp-content/uploads/elementor/thumbs/fav_icon_TTD-r8xkio7ebt5062iunra09m8cc4544reqzr28q6uark.png" title="fav_icon_TTD" alt="fav_icon_TTD" loading="lazy" />															</div>
				</div>
				<div class="elementor-element elementor-element-59554da0 elementor-widget elementor-widget-icon-box" data-id="59554da0" data-element_type="widget" data-e-type="widget" data-widget_type="icon-box.default">
				<div class="elementor-widget-container">
							<div class="elementor-icon-box-wrapper">

			
						<div class="elementor-icon-box-content">

									<h3 class="elementor-icon-box-title">
						<span  >
							Publicado por:						</span>
					</h3>
				
									<p class="elementor-icon-box-description">
						Grupo TTD					</p>
				
			</div>
			
		</div>
						</div>
				</div>
				</div>
				</div>
		]]></content:encoded>
					
					<wfw:commentRss>https://grupottd.org/aspirina-en-bajas-dosis-para-cancer-colorrectal-localizado-con-alteracion-en-pi3k/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
